| Efficacy of citicoline as an acute stroke treatment. | |
| | |
MedLine Citation:
|
PMID: 19351232 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Citicoline (cytidine-5'-diphosphocholine or CDP-choline) is a precursor essential for the synthesis of phosphatidylcholine, one of the cell membrane components that is degraded during cerebral ischemia to free fatty acids and free radicals. Animal studies suggest that citicoline may protect cell membranes by accelerating resynthesis of phospholipids and suppressing the release of free fatty acids, stabilizing cell membranes, and reducing free radical generation. Numerous experimental stroke studies with citicoline have shown improved outcome and reduced infarct size in both ischemic and hemorrhagic stroke models. Citicoline has been studied worldwide in both ischemic and hemorrhagic clinical stroke with excellent safety and possibly efficacy found in several trials. A meta-analysis of four randomized US clinical citicoline trials concluded that treatment with oral citicoline within the first 24 h after a moderate to severe stroke is safe and increases the probability of complete recovery at 3 months. Citicoline clinical efficacy trials are now continuing outside of the US in both ischemic and hemorrhagic stroke. A citicoline supplement is now available from several sources on the internet. |
| | |
Authors:
|
Wayne M Clark |
Publication Detail:
|
Type: Comparative Study; Journal Article; Meta-Analysis |
Journal Detail:
|
Title: Expert opinion on pharmacotherapy Volume: 10 ISSN: 1744-7666 ISO Abbreviation: Expert Opin Pharmacother Publication Date: 2009 Apr |
Date Detail:
|
Created Date: 2009-04-08 Completed Date: 2009-10-02 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100897346 Medline TA: Expert Opin Pharmacother Country: England |
Other Details:
|
Languages: eng Pagination: 839-46 Citation Subset: IM |
Affiliation:
|
Department of Neurology CR131, Oregon Health Sciences University, Oregon Stroke Center, Portland, OR97201, USA. Clarkw@ohsu.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Cytidine Diphosphate Choline / pharmacology, therapeutic use* Humans Nootropic Agents / pharmacology, therapeutic use Randomized Controlled Trials as Topic / methods Stroke / drug therapy*, physiopathology, psychology Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Nootropic Agents; 987-78-0/Cytidine Diphosphate Choline |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Treatment strategies for pelvic inflammatory disease.
Next Document: Duloxetine in the management of elderly patients with major depressive disorder: an analysis of publ...